APC.H — Advanced Proteome Therapeutics Share Price
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -584.94% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Jul | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.
Directors
- Last Annual
- July 31st, 2022
- Last Interim
- April 30th, 2023
- Incorporated
- December 12th, 2005
- Public Since
- April 4th, 1994
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 41,127,080
- Address
- suite 104 8337 Eastlake Dr., BURNABY, V5A 4W2
- Web
- https://www.advancedproteome.com/
- Phone
- +1 6046903797
- Auditors
- Crowe MacKay LLP
Upcoming Events for APC.H
Similar to APC.H
Arkadia Capital
TSX Venture Exchange
Atoro Capital
TSX Venture Exchange
Bravern Ventures
TSX Venture Exchange
China Goldcorp
TSX Venture Exchange
Clear Gold Resources
TSX Venture Exchange
FAQ
What is the Advanced Proteome Therapeutics share price?
As of Today at 19:00 UTC, shares in Advanced Proteome Therapeutics are trading at CA$0.01. This share price information is delayed by 15 minutes.
How has the Advanced Proteome Therapeutics share price performed this year?
Shares in Advanced Proteome Therapeutics last closed at CA$0.01 and the price had moved by -88.89% over the past 365 days. In terms of relative price strength the Advanced Proteome Therapeutics share price has underperformed the Toronto Stock Exchange 300 Composite Index by -89.46% over the past year.
What are the analyst and broker recommendations for Advanced Proteome Therapeutics?
There is no consensus recommendation for this security.
What is the Advanced Proteome Therapeutics dividend yield?
Advanced Proteome Therapeutics does not currently pay a dividend.
Does Advanced Proteome Therapeutics pay a dividend?
Advanced Proteome Therapeutics does not currently pay a dividend.
When does Advanced Proteome Therapeutics next pay dividends?
Advanced Proteome Therapeutics does not currently pay a dividend.
How do I buy Advanced Proteome Therapeutics shares?
To buy shares in Advanced Proteome Therapeutics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Advanced Proteome Therapeutics?
As of the previous close price of CA$0.01, shares in Advanced Proteome Therapeutics had a market capitalisation of .
Where are Advanced Proteome Therapeutics shares listed?
Here are the trading details for Advanced Proteome Therapeutics:
- Country of listing: Canada
- Exchange: NEX
- Ticker Symbol: APC.H
What kind of share is Advanced Proteome Therapeutics?
Based on an overall assessment of its quality, value and momentum Advanced Proteome Therapeutics is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Advanced Proteome Therapeutics share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Advanced Proteome Therapeutics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Proteome Therapeutics. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -56.33%.
As of the last closing price of CA$0.01, shares in Advanced Proteome Therapeutics were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Advanced Proteome Therapeutics PE Ratio?
The Advanced Proteome Therapeutics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Advanced Proteome Therapeutics?
Advanced Proteome Therapeutics' management team is headed by:
- Paul Woodward - CEO
- Kenneth Phillippe - CFO
- W. Benjamin Catalano - IND
- Martin Woodward - IND